Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03737812 |
|---|---|
| Brief Title: | A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis |
| First Submitted : | November 6, 2018 |
| First Submitted that Met QC Criteria : | November 8, 2018 |
| First Posted : | November 13, 2018 |
| Certification/Extension First Submitted : | December 15, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | December 15, 2021 |
| Certification/Extension First Posted : | December 20, 2021 |
| Last Update Submitted that Met QC Criteria : | December 15, 2021 |
| Last Update Posted : | December 20, 2021 |